Comprehensive analysis of pivotal biomarkers, immune cell infiltration and therapeutic drugs for steroid-induced osteonecrosis of the femoral head

Bo Wang, Song Gong, Wenkai Shao, Lizhi Han, Zilin Li, Zhichao Zhang, Zheng Yang, Fang Ouyang, Yan Ma, Weihua Xu, Yong FengBioengineered 2021 · DOI

TL;DR

This study comprehensively analyzes gene expression data from patients with steroid-induced osteonecrosis of the femoral head (SONFH) to identify key biomarkers, understand immune cell involvement, and discover potential therapeutic drugs. The findings highlight the role of myeloid leukocyte activation and osteoclast differentiation in SONFH pathogenesis and suggest aspirin as a promising therapeutic agent.

What Problem Does This Paper Address?

Steroid-induced osteonecrosis of the femoral head (SONFH) is a debilitating condition that significantly impacts quality of life, often leading to hip joint replacement. Despite its prevalence, the exact mechanisms driving SONFH remain unclear, hindering the development of effective early diagnostic tools and targeted therapies. While inflammation and immune cell involvement have been implicated, a detailed understanding of which specific immune cells and molecular pathways are involved, along with the identification of reliable biomarkers and potential drug candidates, is still needed. This paper aims to fill this gap by providing a multi-faceted analysis of gene expression, immune cell infiltration, and drug screening in SONFH.

Methods

The researchers employed a multi-pronged bioinformatics approach combined with experimental validation.

  • Gene Expression Analysis: They downloaded the GSE123568 dataset from the Gene Expression Omnibus (GEO) database, which contains gene expression profiles from SONFH patients and healthy controls. Differentially expressed genes (DEGs) were identified using the NetworkAnalyst platform, with specific criteria for adjusted p-value and log fold change.
  • Functional Enrichment and Pathway Analysis: Metascape was used to analyze the identified DEGs for enriched Gene Ontology (GO) terms (biological process, cellular component, molecular function) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.
  • Protein-Protein Interaction (PPI) Network Analysis: Metascape was also utilized for PPI network construction, and the MCODE algorithm was applied to identify significant modules within the network.
  • Immune Cell Infiltration Analysis: The ImmuCellAI algorithm was employed to assess the abundance of 24 different immune cell types in SONFH and control samples.
  • Hub Gene Identification and Validation: Hub genes, representing the most highly connected genes in the PPI network, were identified using the maximal clique centrality (MCC) evaluation via the cytoHubba plugin in Cytoscape. The expression of these hub genes was then validated using quantitative real-time PCR (qRT-PCR) on clinical serum samples.
  • Drug Prediction: The L1000 platform (connectivity map) was used to predict potential therapeutic drugs for SONFH by comparing DEG signatures with a database of compounds.
  • In Vivo Validation: A mouse model of glucocorticoid-induced ONFH was established to evaluate the therapeutic effect of aspirin, a predicted drug candidate.

Datasets

  • GSE123568 dataset: This dataset from the Gene Expression Omnibus (GEO) database was the primary source of gene expression data, comprising 40 peripheral serum samples from SONFH patients and 10 from healthy controls.
  • Clinical serum samples: Peripheral serum samples from six SONFH patients and six healthy controls were used for qRT-PCR validation of hub genes.
  • SONFH mouse model: A mouse model was used to experimentally validate the therapeutic effect of aspirin.

Key Insights and Ideas

  • Myeloid Leukocyte Activation as a Driver: The study strongly suggests that myeloid leukocyte activation, along with processes like positive regulation of cytokine production and myeloid cell differentiation, are central to the pathogenesis of SONFH. This points towards an inflammatory component being a key player.
  • Osteoclast Differentiation Link: The enrichment analysis revealed a significant involvement of osteoclast differentiation pathways. This aligns with the known role of osteoclasts in bone resorption and suggests that dysregulation of this process is critical in SONFH.
  • Distinct Immune Cell Signatures: The research identified significant differences in the infiltration of specific immune cell types between SONFH patients and controls. Notably, an increase in naive CD8+ T cells and macrophages, and a decrease in exhausted T cells, iTregs, Th1 cells, and others, were observed. This highlights a complex immune dysregulation in the disease.
  • Synergistic Role of Macrophages and Monocytes: The strong correlation between macrophages and monocytes, coupled with their increased presence in SONFH, suggests a synergistic effect in disease development, potentially through their role as osteoclast precursors.
  • Aspirin as a Potential Therapeutic: The study successfully predicted aspirin as a potential therapeutic agent using the L1000 platform. Subsequent in vivo experiments in a mouse model demonstrated that aspirin could protect against glucocorticoid-induced ONFH, supporting its potential clinical utility.

Key Results

  • 429 Differentially Expressed Genes (DEGs): The analysis identified a substantial number of DEGs between SONFH and control samples, forming the basis for further functional analysis.
  • 10 Hub Genes Identified: Ten key genes (CCR1, CCR2, CCR3, CXCR1, FPR2, HCAR2, PF4, CXCR2, CXCL5, and P2RY13) were identified as pivotal in the SONFH PPI network and showed significantly altered expression in SONFH patients.
  • Nine Immune Cell Types Differentially Abundant: The ImmuCellAI analysis revealed significant differences in the abundance of at least nine immune cell types between SONFH and control groups.
  • Aspirin Ameliorates GC-induced ONFH in Mice: In the mouse model, aspirin treatment led to increased bone volume/total volume (BV/TV) and reduced empty lacunae rate, indicating a protective effect against glucocorticoid-induced damage.

Limitations and Future Work

  • Small Sample Size: The authors acknowledge that the relatively small sample size of the initial dataset may have led to lower statistical power for gene expression analysis. They plan to collect more specimens for future testing.
  • Clinical Trial Needed for Aspirin: While the mouse model showed promising results for aspirin, the authors emphasize that follow-up clinical trials are necessary to confirm its efficacy in human patients.
  • Molecular Mechanism of Aspirin: Further research is needed to fully elucidate the molecular mechanisms by which aspirin exerts its inhibitory effects on SONFH.
  • Role of Specific Hub Genes: The exact roles of some identified hub genes (e.g., CCR1, FPR2, HCAR2, P2RY13) in SONFH remain unclear and warrant further investigation.
  • Detailed Immune Cell Mechanisms: While differences in immune cell infiltration were observed, the precise mechanisms by which these cells contribute to SONFH pathogenesis require more in-depth study.

Summary updated

Abstract

Steroid-induced osteonecrosis of the femoral head (SONFH) is a progressive disease that leads to an increased disability rate. This study aimed to ascertain biomarkers, infiltrating immune cells, and therapeutic drugs for SONFH. The gene expression profile of the GSE123568 dataset was downloaded from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were identified using the NetworkAnalyst platform. Functional enrichment, protein-protein interaction network (PPI), and module analyses were performed using Metascape tools. An immune cell abundance identifier was used to explore immune cell infiltration. Furthermore, hub genes were identified based on maximal clique centrality (MCC) evaluation using cytoHubba application and confirmed by qRT-PCR using clinical samples. Finally, the L1000 platform was used to determine potential drugs for SONFH treatment. The SONFH mouse model was used to determine the therapeutic effects of aspirin. In total, 429 DEGs were identified in SONFH samples. Functional enrichment analysis showed that these DEGs were enriched in myeloid leukocyte activation and osteoclast differentiation processes. A set of nine immune cell types was confirmed to be markedly different between the SONFH and control samples. All 10 hub genes were significantly highly expressed in the serum of SONFH patients, as shown by qRT-PCR. Finally, the therapeutic effect of aspirin on SONFH was examined in animal experiments. Taken together, our data revealed the hub genes and infiltrating immune cells in SONFH, and we also screened potential drugs for use in SONFH treatment.
BibTeX
@inproceedings{wang2021comprehensive,
  author = {Bo Wang and Song Gong and Wenkai Shao and Lizhi Han and Zilin Li and Zhichao Zhang and Zheng Yang and Fang Ouyang and Yan Ma and Weihua Xu and Yong Feng},
  title = {{Comprehensive analysis of pivotal biomarkers, immune cell infiltration and therapeutic drugs for steroid-induced osteonecrosis of the femoral head}},
  booktitle = {Bioengineered},
  year = {2021},
  doi = {10.1080/21655979.2021.1972081},
}
Figure